TNP-470, an angiogenesis inhibitor, attenuates the development of allograft vasculopathy. [electronic resource]
Producer: 20041116Description: 1218-21 p. digitalISSN:- 0041-1337
- Abdomen
- Angiogenesis Inhibitors -- administration & dosage
- Animals
- Coronary Disease -- etiology
- Cyclohexanes
- Cyclosporine -- administration & dosage
- Drug Administration Schedule
- Drug Therapy, Combination
- Graft Survival -- drug effects
- Heart Transplantation -- adverse effects
- Male
- O-(Chloroacetylcarbamoyl)fumagillol
- Rats
- Rats, Inbred F344
- Rats, Inbred Lew
- Sesquiterpenes -- administration & dosage
- Transplantation, Heterotopic
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.